Ronan Talty, MD, PhD

Dr. Talty is an MD/PhD student at Yale School of Medicine. Prior to medical school, he graduated summa cum laude from Northeastern University with a degree in behavioral neuroscience. There, he completed research projects on pathological neural network activation in seizures, the impact of charged particle radiation on cognitive function, and the ability of estrogen to modulate dopamine action in the brain and affect memory for traumatic events, and received multiple conference awards, research fellowships, and university honors.

During medical school, Dr. Talty developed a passion for cancer biology and earned his PhD studying melanoma under the mentorship of Dr. Marcus Bosenberg. His thesis research focused on ferroptosis, a novel form of regulated cell death. He investigated the role of ferroptosis in endogenous and immunotherapy-induced antitumor immunity, pharmacologic strategies to enhance intratumoral ferroptosis and immunotherapy responses, and the impact of mutations in oncogenes such as BRAF, NRAS, and KRAS on ferroptosis sensitivity. He has delivered oral presentations on his work to international audiences at the Society for Melanoma Research and American Association for Cancer Research annual meetings. His research is supported by an NRSA F30 predoctoral fellowship from the National Cancer Institute and a medical student grant from the American Skin Association

Dr. Talty maintains a broad interest in tumor immunology and metabolism. His clinical interests include dermatology, inflammatory skin disorders, and melanoma and other skin cancers. Starting this July, he will complete his intern year at Memorial Sloan Kettering Cancer Center before his dermatology residency at New York University Grossman School of Medicine.